Q2 2026 Holdings
Filed 2026-08-13 | 73 holdings | $962.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $55.0M | 206,234 | 5.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $52.4M | 500,996 | 5.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $49.6M | 1,280,707 | 5.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $47.9M | 1,301,979 | 5.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $42.7M | 2,017,009 | 4.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $38.0M | 390,000 | 4.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $34.6M | 311,461 | 3.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $33.6M | 352,802 | 3.5% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $26.8M | 1,108,295 | 2.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $26.5M | 1,214,390 | 2.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $24.8M | 489,382 | 2.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $23.9M | 619,096 | 2.5% |
| Erasca Inc(ERAS) | COM | 29479A108 | $23.1M | 1,263,026 | 2.4% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $22.6M | 2,927,698 | 2.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $22.6M | 169,593 | 2.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $22.0M | 65,679 | 2.3% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $21.3M | 546,256 | 2.2% |
| ARK ETF TRPut | PUT | 00214Q952 | $21.0M | 500,000 | 2.2% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $18.8M | 400,000 | 2.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $18.7M | 318,001 | 1.9% |
| Syndax Pharmaceuticals IncCall | CALL | 87164F905 | $15.2M | 693,600 | 1.6% |
| Guardant Health Inc(GH) | COM | 40131M109 | $15.0M | 99,826 | 1.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $14.2M | 3,032,060 | 1.5% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $12.9M | 509,789 | 1.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $12.6M | 678,095 | 1.3% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $12.5M | 1,177,821 | 1.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $11.9M | 5,744,757 | 1.2% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $11.7M | 95,000 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.3M | 186,821 | 1.2% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $10.9M | 330,487 | 1.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $10.4M | 48,101 | 1.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $10.3M | 1,946,482 | 1.1% |
| Cerus Corp(CERS) | COM | 157085101 | $10.1M | 3,472,737 | 1.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $9.2M | 500,402 | 1.0% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $9.1M | 679,826 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.4M | 145,000 | 0.9% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $8.4M | 122,269 | 0.9% |
| Savara Inc(SVRA) | COM | 805111101 | $8.3M | 1,355,459 | 0.9% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $8.3M | 3,101,129 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.0M | 738,873 | 0.8% |
| Oric Pharmaceuticals IncCall | CALL | 68622P909 | $7.4M | 682,600 | 0.8% |
| Monte Rosa Therapeutics IncCall | CALL | 61225M902 | $7.3M | 300,000 | 0.8% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $7.1M | 503,382 | 0.7% |
| Compugen LTD(CGEN) | ORD | M25722105 | $6.8M | 3,184,257 | 0.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $6.7M | 668,450 | 0.7% |
| Abivax SACall | CALL | 00370M903 | $6.7M | 50,000 | 0.7% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $6.2M | 3,520,490 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.1M | 82,800 | 0.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $5.9M | 113,494 | 0.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $5.3M | 59,959 | 0.6% |